Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pMIR-CDH1 wtUTR Citations (2)

Originally described in: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA Nat Cell Biol. 2010 Mar . 12(3):247-56.
PubMed Journal

Articles Citing pMIR-CDH1 wtUTR

Articles
Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway. Drakaki A, Hatziapostolou M, Polytarchou C, Vorvis C, Poultsides GA, Souglakos J, Georgoulias V, Iliopoulos D. BMC Cancer. 2015 Jul 24;15:542. doi: 10.1186/s12885-015-1562-9. PubMed
miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis. Seashols-Williams SJ, Budd W, Clark GC, Wu Q, Daniel R, Dragoescu E, Zehner ZE. PLoS One. 2016 Jul 22;11(7):e0159601. doi: 10.1371/journal.pone.0159601. eCollection 2016. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.